The onchocerciasis chronicle: From the beginning to the end?

Trends in Parasitology

Volumn 28, Issue 7, 2012, Pages 280-288

  Crump, Andy ^a   Morel, Carlos M ^b   Omura, Satoshi ^a  

^a KITASATO INSTITUTE   (Japan)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Disease control; Disease elimination; Ivermectin; Onchocerciasis; Vector control

Indexed keywords

AFRICA; AGRICULTURAL WORKER; DISEASE CARRIER; HUMAN; INFECTION RATE; MOSQUITO; ONCHOCERCA; ONCHOCERCA CAECUTIENS; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARASITE CLEARANCE; PARASITE IDENTIFICATION; PREVALENCE; REVIEW; RIVER; RURAL AREA; SIMULIIDAE; SIMULIUM; SKIN NODULE; VECTOR CONTROL; VERTICAL TRANSMISSION; WESTERN HEMISPHERE;

ANIMALS; DELIVERY OF HEALTH CARE; DISEASE ERADICATION; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INSECT CONTROL; IVERMECTIN; ONCHOCERCA; ONCHOCERCIASIS; SIMULIIDAE;

EID: 84862317625     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2012.04.005     Document Type: Review

References (94)

1. Ridley N.H.L. Ocular onchocerciasis: including an investigation in the Gold Coast. Br. J. Ophthalmol. 1945, 29(Suppl.):1-58.
2. Hodgkin C., et al. The future of onchocerciasis control in Africa. PLoS Negl. Trop. Dis. 2007, 1:e74.
3. Gaillard, J. et al. (2005) Africa. In UNESCO, World Science Report, pp. 177-202, UNESCO.
4. World Health Organization First WHO Report on Neglected Tropical Diseases: Working to Overcome the Global Impact of Neglected Tropical Diseases 2010, WHO.
5. Ruiz Reyes F. Datos historicos sobre el origen de la onchocercosis en America. Rev. Méd. Mex. 1952, 32:49-56.
6. UNESCO Struggles against Slavery 2004, UNESCO. http://unesdoc.unesco.org/images/0013/001337/133738e.pdf.
7. Grove D.I. A History of Human Helminthology 1990, CAB International.
8. Lammie P., et al. Eliminating lymphatic filariasis, onchocerciasis, and schistosomiasis from the Americas: breaking a historical legacy of slavery. PLoS Negl. Trop. Dis. 2007, 1:e71.
9. Manson P. Report of a case of Bilharzia from the West Indies. Br. Med. J. 1902, ii:1894-1895.
10. Zimmerman P.A., et al. Recent evolutionary history of American Onchocerca volvulus, based on analysis of a tandemly repeated DNA sequence family. Mol. Biol. Evol. 1994, 11:384-392.
11. O'Neil J. On the presence of a filarial in "craw craw" Lancet 1875, i:265-266.
12. Hygiene and Diseases of Warm Climates 1893, Young J. Pentland. A. Davidson (Ed.).
13. Labadie-Lagrave F., Deguy F. Un cas de Filaria volvulus. Arch. Parasitol. 1899, 2:451-460.
14. Prout W.T. A filarial found in Sierra Leone - Filaria volvulus (Leuckart). Br. Med. J. 1901, i:209-211.
15. Railliet A., Henry A.C. Remarques à l'occasion de la note de M. le Dr. Antoine. Bull. Soc. Pathol. Exot. Filiales 1910, 3:91-93.
16. Ouzilleau F. Les filaires dumaines de la Région du M'Bomou (Afrique équatoriale française). Pathogénie de l'éléphantiasis de cette region. Rôle de la Filaria volvulus. Bull. Soc. Pathol. Exot. Filiales 1913, 7:80-88.
17. Robles R. Enfermedad nueva en Guatemala. La Juventud Médica 1917, 17:97-115.
18. Robles R. Onchocercose humaine au Guatémala produisant la cêcité et "l'érysipéle du littoral" (Erisipela de la costa). Bull. Soc. Pathol. Exot. Filiales 1919, 12:442-460.
19. Brumpt E. Une nouvelle filaire pathogèn e parasite de l'homme (Onchocerca caecutiens, n. sp.). Bull. Soc. Pathol. Exot. Filiales 1919, 12:464-473.
20. Montpellier J., Lacroix A. Le "craw craw" ou "gale filairienne"; son origine dans les kystes sous-cutanées à Onchocerca volvulus. Bull. Soc. Pathol. Exot. 1920, 13:305-315.
21. Ouzilleau F. L'éléphantiasis au Congo et l'Onchocerca volvulus. La Presse Médicale 1923, 31:617-622.
22. Blacklock D.B. The development of Onchocerca volvulus in Simulium damnosum. Ann. Trop. Med. Parasitol. 1926, 20:1-48.
23. Blacklock D.B. The further development of Onchocerca volvulus in Simulium damnosum (Theob). Ann. Trop. Med. Parasitol. 1926, 20:203-218.
24. Blacklock D.B. The insect transmission of Onchocerca volvulus (Leuckart 1893), the cause of worm nodules in man in Africa. Br. Med. J. 1927, i:129-133.
25. Fülleborn F. The "blinding filarial" of Guatemala (Onchocerca caecutiens, Brumpt 1919). Proceedings of the International Conference on Health Problems in Tropical Countries 1924, 241-255. United Fruit Company.
26. Silva R. Ocular onchocerciasis. South. Med. J. 1932, 25:113-117.
27. Ochoterena I. Contribución para el conocimiento de la onchocercosis en Mexico. Anales del Instituto Biologia Universidad Nacional de Mexico 1928, 1:59-62.
28. Ochoterena I. Contributiones para onchocerciasis en Mexico. Anales del Instituto Biologia Universidad Nacional de Mexico 1930, 1:307-309.
29. Hissette J. Sur l'existence d'affections oculaires importantes d'origine filarienne dans certains territoires du Congo. Annales de la Société Belge de Médecine Tropicale 1931, 11:45-46.
30. Hissette J. Mémoire sur l'Onchocerca volvulus "Leuckart" et ses manifestations oculaires au Congo Belge. Annales de la Société Belge de Médecine Tropicale 1932, 12:433-529.
31. Strong R.P. Onchocerciasis in Africa and Central America, I. Am. J. Trop. Med. 1938, 18(Suppl.):1-57.
32. Torroella J.L. Contribución al estudio de la onchocercosis de sus manifestiaciones oculares. Anales del Instituto de Biología Universidad Nacional de Mexico 1930, 1:201-203.
33. Hoffmann C.C. über Onchocerca im Süden von Mexico und die Weiterentwicklung ihrer Mikrofilarien in Eusimulium mooseri. Arch. Schiffs. Trop. Hyg. 1930, 34:461-472.
34. Strong R.P. Onchocerciasis in Central America and Africa. Trans. R. Soc. Trop. Med. Hyg. 1937, 30:487-499.
35. Dampf A. La carretera panamericana y el problema de la oncocercosis. Bol. Ofic. Sanit. Panamer. 1942, 21:753-758.
36. Brown A.W.A. A survey of Simulium control in Africa. Bull. WHO 1962, 27:511-527.
37. Garnham P.C., McMahon J.P. The eradication of Simulium neavei Roubaud from an onchocerciasis area in Kenya colony. Bull. Ent. Res. 1947, 37:619-628.
38. Mazzotti I. Posibilidad de utilizar como medio diagnostico auxiliar en la oncocercosis, las reacciones alergicas consecutivas a la administracion del "Hetrazan" Revista del Instituto Salubridad y Enfermedades Tropicales Mexico 1948, 9:235-237.
39. Garms R., et al. Studies on the re-invasion of the Onchocerciasis Control Programme in the Volta River Basin by Simulium damnosum s.1. with emphasis on the south-western areas. Tropenmed. Parasitol. 1979, 30:345-362.
40. Kershaw W.E., et al. Distribution of microfilariae of O. volvulus in the skin. Its relation to the skin changes and to eye lesions and blindness. Br. Med. J. 1954, i:724-729.
41. Ōmura S., Crump A. The life and times of ivermectin: a success story. Nat. Rev. Microbiol. 2005, 2:984-989.
42. World Health Organization Ten Years of Onchocerciasis Control in West Africa: Review of the Works of the Onchocerciasis Control Programme in the Volta River Basin Area from 1974-1984 1985, WHO.
43. Le Berre R., et al. Displacements of Simulium damnosum and strategy of control against Onchocerciasis. Philos. Trans. R. Soc. Lond. B 1979, 287:277-288.
44. Aziz M.A., et al. Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet 1982, 2:171-173.
45. Aziz M.A., et al. Ivermectin in onchocerciasis. Lancet 1982, 2:1456-1457.
46. Campbell W.C. Ivermectin as an antiparasitic agent for use in humans. Annu. Rev. Microbiol. 1991, 45:445-474.
47. Crump A., Ōmura S. Ivermectin, 'wonder drug' from Japan: the human use perspective. Proc. Jpn. Acad. Ser. B: Phys. Biol. Sci. 2011, 87:13-28.
48. Haddad D. The NGDO coordination group for Onchocerciasis control. Ann. Trop. Med. Parasitol. 2008, 102(Suppl. 1):35-38.
49. Ngoumou P., et al. A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. Ann. Trop. Med. Parasitol. 1994, 88:463-474.
50. Keiser P.B., et al. Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of post-treatment reactions. J. Infect. Dis. 2002, 185:805-811.
51. Hoerauf A., Pfarr K. Wolbachia endosymbionts: an Achilles' heel of filarial nematodes. Wolbachia: A Bug's Life in Another Bug 2007, 31-51. Karger. A. Hoerauf, R.U. Rao (Eds.).
52. Kluxen G. Dr. Jean Hissette's Research Expeditions to Elucidate River Blindness 2011, Kaden.
53. Taylor M.J. Wolbachia in the inflammatory pathogenesis of human Filariasis. Ann. N. Y. Acad. Sci. 2003, 990:444-449.
54. Hoerauf A., et al. Doxycycline in the treatment of human Onchocerciasis: kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Microbes Infect. 2003, 5:261-273.
55. World Health Organization/African Programme for Onchocerciasis Control Future of APOC 2011, WHO.
56. Habbema, J.D.F. et al. (2007) Health Impact Assessment, Erasmus University and African Programme for Onchocerciasis Control, WHO Department of Control of Neglected Tropical Diseases. http://www.who.int/apoc/publications/APOC%20rapid%20HIA_final%20report_def.pdf.
57. Diawara L., et al. Feasibility of Onchocerciasis elimination with ivermectin treatment in endemic foci in Africa; first evidence from studies in Mali and Senegal. PLoS Negl. Trop. Dis. 2009, 3:e497.
58. World Health Organization Integrated Preventive Chemotherapy for Neglected Tropical Diseases: Estimation of the Number of Interventions Required and Delivered, 2009-2010 2012, WHO.
59. World Health Organization/African Programme for Onchocerciasis Control Fifteen Years of Working with Communities to eliminate River Blindness 2011, WHO.
60. World Health Organization/African Programme for Onchocerciasis Control (2011) WHO African Programme for Onchocerciasis Control: Progress Report 2011, WHO.
61. World Health Organization African Programme for Onchocerciasis Control: Meeting of National Task Forces, September 2011. Wkly. Epidemiol. Rec. 2011, 48-86:541-549.
62. World Health Organization/African Programme for Onchocerciasis Control Final Communiqué 17th Session of the Joint Action Forum, Kuwait City, Kuwait, 12-14 December, 2011 2012.
63. Mectizan Donation Programme (2012) Annual Highlights 2011: Celebrating 25 years of the Mectizan Donation Program in 2012. http://www.mectizan.org/sites/default/files/Annual%20Highlights%202011%20English.pdf.
64. Mackenzie C.D., et al. Elimination of onchocerciasis from Africa: possible?. Trends Parasitol. 2012, 28:16-22.
65. World Health Organization Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases: A Roadmap for Implementation 2012, WHO.
66. Liese, B. et al. (1991) Organizing and Managing Tropical Disease Control Programmes: Lessons of Success, World Bank Technical Paper No. 159, World Bank.
67. Ubachukwu P.O. Human onchocerciasis: epidemiological status of Uzo-Uwari local government area of Enugu State Nigeria. Nig. J. Parasitol. 2004, 25:93-99.
68. Usip L.P.E., et al. Longitudinal evaluation of repellent activity of Ocimium gratissimum (Labiatae) volatile oil against Simulium damnosum. Mem. Inst. Oswaldo Cruz 2006, 101:201-205.
69. Adeleke M.A., et al. Socioeconomic implications of Simulium damnosum complex infestation in some rural communities in Odeda local government area of Ogun State,Nigeria. J. Public Health Epidemiol. 2010, 2:109-112.
70. Currie D.C., Adler P.H. Global diversity of blackflies (Diptera, Simuliidae) in fresh water. Hydrobiologia 2008, 595:469-475.
71. Duke B.O.L. Experimental transmission of Onchocerca volvulus to chimpanzees. Trans. R. Soc. Trop. Med. Hyg. 1962, 56:271.
72. Roberts J.M., et al. Onchocerciasis in Kenya 9, 11 and 18 years after elimination of the vector. Bull. WHO 1967, 37:195-212.
73. Duke B.O.L. The intake and transmissibility of Onchocerca volvulus microfilariae by Simulium damnosum fed on patients treated with Diethylcarbamazine, Suramin or Mel W. Bull. WHO 1968, 39:169-178.
74. Kipp W., et al. The Nakalanga syndrome in Kabarole District, Western Uganda. Am. J. Trop. Med. Hyg. 1996, 54:80-83.
75. Crump A. Outstanding, innovative disease control solution meets a minor hitch (TDR Photofeature 4). App. Tech. 2003, 30:13-17.
76. Donnelly J. CDC planning trial for mysterious Nodding syndrome. Lancet 2012, 379:299.
77. van Hoof L., et al. Sur la chimiothérapie de l'onchocercose. Ann. Soc. Belge Méd. Tropicale 1947, 27:173-177.
78. Hewitt R.I., et al. Experimental chemotherapy of filariasis. J. Lab. Clin. Med. 1947, 32:1293-1329.
79. Duke B.O. The reappearance, rate of increase and distribution of the microfilariae of Onchocerca volvulus following treatment with diethylcarbamazine. Trans. R. Soc. Trop. Med. Hyg. 1957, 51:37-44.
80. Duke B.O.L. The effects of drugs on Onchocerca volvulus. 3. Trials of suramin at different dosages and a comparison of the brands Antrypol, Moranyl and Naganol. Bull. WHO 1968, 39:157-167.
81. Duke B.O.L. The effects of drugs on Onchocerca volvulus. Bull. WHO 1968, 39:137-146.
82. Abdi Y.A., et al. Handbook of Drugs for Tropical Parasitic Infections 1995, Taylor and Francis. 2nd edn.
83. Burg R.W., et al. Avermectins, new family of potent anthelmintic agents: producing organisms and fermentation. Antimicrob. Agents Chemother. 1979, 15:361-367.
84. Miller T.W. Avermectins, new family of potent anthelmintic agents: isolation and chromatographic properties. Antimicrob. Agents Chemother. 1979, 15:368-371.
85. 1A component. Antimicrob. Agents Chemother. 1979, 15:372-378.
86. Blair L.S., Campbell W.C. Efficacy of avermectins against Ancylostoma caninum in dogs. J. Helminthol. 1978, 52:305-307.
87. Campbell W.C., Blair L.S. Efficacy of avermectins against Dirofilaria immitis in dogs. J. Helminthol. 1978, 52:308-310.
88. Mode of action of avermectin. Macrolide Antibiotics; Chemistry, Biology and Practice 2002, 571-575. Academic Press. 2nd edn. S. ōmura (Ed.).
89. Cully D.F., et al. Cloning of an ivermectin-sensitive glutamate-gated chloride channel form Caenorhabditis elegans. Nature 1994, 371:707-711.
90. Awadzi K. The chemotherapy of onchocerciasis II: quantification of the clinical reaction to microfilaricides. Ann. Trop. Med. Parasitol. 1980, 74:189-197.
91. Awadzi K., et al. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis. Ann. Trop. Med. Parasitol. 1985, 79:63-78.
92. Molyneux D.H., et al. Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol. 2003, 19:516-522.
93. Carter G.T., et al. LL-F28249 antibiotic complex: a new family of antiparasitic macrocyclic lactones: isolation, characterization and structures of LL-F28249 (alpha, beta, gamma, delta). J. Antibiot. 1988, 4:519-529.
94. Rock D.W., et al. Moxidectin. Macrocyclic Lactones in Antiparasitic Therapy 2002, CABI Publishing. J. Vercruysse, R.S. Rew (Eds.).